The only certified INUSpheresis® Clinic in Greece
INUSpheresis Athens Clinic
As of 2022, the INUSpheresis Athens Clinic is one of registered INUSpherese® Centers in Europe. We follow the guidelines of other international apheresis societies when determining indications and answering questions regarding apheresis therapy. We also provide top-quality health services from experts with long-time experience and vision.
As a procedure based on the laws of thermodynamics, INUS was the first institution to use this method specifically for chronic diseases in environmental medicine and as a prevention. At INUS Athens, we offer an individually adapted, intelligent better aging concep for each of our patients.
Apheresis as an effective, clinically proven treatment and disease-prevention therapy
How INUSPHERESIS® works
Environmental toxins are based on Haber’s rule where the longer they linger, the more toxic they get whereas INUSpheresis® operates according to the laws of thermodynamics which enables detoxification and elimination of toxins through the duration and number of performed therapies.
INUSpheresis®, an innovative part of the INUS concept, uses intelligent, effective detox filters which can remove malformed autoimmune antibodies, inflammation mediators, environmental toxins, virus particles, etc. from the body with almost no side effects.
Based on several years of experience gained by phlebotomy therapists, this modern treatment is a special form of high-tech plasma purification and immunomodulation for chronic and acute metabolic and immune disorders.
It is used at the INUS Athens Clinic for environmental pollution, rheumatic diseases, lipid disorders, chronic diseases, inflammations, and autoimmune diseases. After the first INUSpheresis® session, these pathogenic agents are significantly decreased and can be removed completely by repetition.
The INUSpherese® process
1.Analysis
INUSpheresis® filters out pathogenic structures in the blood which are then subjected to chemical and biochemical analyses to measure excreted toxin levels and plasma residues. These analysis results serve to monitor the treatment process.
2. Restoring Blood
Blood is collected and returned via arm veins with special cannulas. The disease-causing substances are filtered out and eliminated while the purified plasma returns to the body with all its good components.
3.Indications
The benefits of INUSpheresis® are best evident in autoimmune, inflammatory rheumatoid arthritis, polyneuropathy, and chronic fatigue syndrome. In such cases, the circulating immune complexes are greatly decreased.
Indications for INUSpheresis®
INUSpheresis® has a wide range of applications. It is suitable for people as a preventive measure, but also as an acute measure. Thus, this treatment can be used for the following clinical pictures and areas, among others:
- Age-related macular degeneration – dry course
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Ulcerative colitis – failure of chemotherapy and/or threat of surgical removal of the bowel
- Diabetic foot syndrome with threatened amputation of limbs in the event of failure of conservative and conventional surgical therapy
- Dilated cardiomyopathy – beta-receptor antibody positive detection
- Eaton-Lambert syndrome (tumor-associated nerve disorder)
- Encephalitis disseminata (multiple sclerosis) – failure of interleukin-alpha therapy or antibody formation against therapeutic interleukin with progressive course
- Familial heterocygous hypercholesterolemia with failure/NW of conservative therapy and/or premature and progressive atherosclerosis/heart attack/stroke/attack on renal vessels
- Familial homocygous hypercholesterolemia
- Focal sclerosing glomerulonephritis of the autologous kidneys or after kidney transplantation with nephrotic syndrome and/or severe hypertriglyceridemia with failure of chemotherapy/cholesterol synthesis inhibitor therapy and rapid increase in renal insufficiency (loss of kidney function)
- Glomerulonephritis (inflammatory kidney disease) pathogenetically directed – failure and/or severe side effects of chemotherapy
- Guillain Barre Syndrome – chronic/acute form
- Haemophilia (hemophilia) with detection of antibodies against factor V
- Inhibitor haemophilia (tendency to bleed) with factor V antibody detection
- HLA sensitization in kidney transplantation
- IgM associated polyneuropathy (tumour-associated nerve disorder)
- Isolated familial Lp(a) hyperlipoproteinemia with premature atherosclerosis/heart attack/stroke/attack of renal vessels/operable arterial occlusive leg disease
- Cryoglobulinemic vasculitis (autoimmune vasculitis caused by cold proteins)
- Linear IgA dermatosis
- Lupus erythematosus in failure/severe side effects of chemotherapy
- Lupus erythematosus with progressive renal involvement (glomerulonephritis)
- macular degeneration (adult form = adult) – dry form
- Behcet’s disease – failure and/or severe side effects of chemotherapy
- Raynaud’s disease – failure of conservative therapy
- Refsum disease (memory disease)
- Multiple sclerosis (see also Encephalitis disseminata)
- Necrobiotic xanthogranulomatosis (with paraprotein)
- Nephrotic syndrome in inflammatory kidney disease (glomerulonephritis)
- pathogenetically guided – failure and/or severe side effects of chemotherapy
- Pemphigus foliaceus failure and/or severe side effects of chemotherapy
- Pemphigus vulgaris failure and/or severe side effects of chemotherapy
- Peripheral arterial occlusive disease (pathogenetically directed) in the event of failure of conservative and conventional surgical therapy options and threatened loss of limbs
- Polymyositis – failure and/or severe side effects of chemotherapy
- Retinopathy pigmentosa in Refsum disease
- Rheumatoid arthritis – in failure of chemotherapy and extreme progression
- Scleroderma progressive systemic with renal involvement (glomerulonephritis)
- Scleromyxedema Arndt-Gottron – with kidney infestation and detection of paraprotein – failure and/or severe side effects of chemotherapy
- Stiff-Man syndrome
- Thrombangiitis obliterans (alternative to amputation)
- Transplant vasculopathy after heart transplant
- Xanthogranulomatosis (necrobiotic) with paraprotein
Frequently asked Questions
What exactly is eliminated from the body?
How INUSpheresis® is performed?
What are the benefits of INUSpheresis®?
What substances usually eliminated during INUSpheresis®?
How will my blood be replaced?
How can I expect to feel after apheresis?
How does INUSpherese® directly impact physical health?
How can rheumatic patients benefit from INUSpheresis®?
How can INUSpheresis® be used in chronic fatigue syndrome?
Can INUSpheresis® benefit patients with coronary heart diseases?
Can INUSpheresis® help if I have hepatitis C?
Is INUSpheresis® some sort of dialysis?
How Does INUSpherese® Differ from other procedures?
Does INUSpherese® Differ from plasma exchange?
Are INUSpheresis® and therapeutic apheresis the same?
Does INUSpherese® Differ from plasma exchange?
How I know if I can have INUSpheresis®?
Benefits of Inuspheresis® Treatment
- Wonderful Substitute Method for Purifying the Blood and Elimination of All the Pathogenic Components
- Sinificantly Improves Microcirculation
- Treating Various Chronic Conditions
- Replacement for Some Intolerable Medicines
- Backflow of All Vital Proteins
- Great Prevention Role
- Can be Done as an Outpatient and Inpatient Procedures
- Easy and Quick Procedure
